Exploring the flexibilities in TRIPS: Lessons from India’s pharmaceutical patent law

Research output: Contribution to journalArticlepeer-review

Abstract

This article examines the extent to which the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS Agreement) permits countries to utilize two key flexibilities, i.e. the exclusion of new forms of known drugs from patent protection and local working requirements to facilitate access to affordable medicines and foster domestic pharmaceutical innovation. It examines how India has implemented and recently utilized these two key flexibilities and concludes with the view that other developing countries can equally follow the Indian model.
Original languageEnglish
Pages (from-to)82-106
JournalCommonwealth Law Bulletin
Volume41
Issue number1
DOIs
Publication statusPublished - 20 Mar 2015

Fingerprint

Dive into the research topics of 'Exploring the flexibilities in TRIPS: Lessons from India’s pharmaceutical patent law'. Together they form a unique fingerprint.

Cite this